Naomoto Yoshio, Takaoka Munenori, Okawa Takaomi, Nobuhisa Tetsuji, Gunduz Mehmet, Tanaka Noriaki
Department of Gastroenterological Surgery, Transplant and Surgical Oncology, Graduate School of Medicine and Dentistry, Okayama University, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.
Oncol Rep. 2005 Jul;14(1):3-8.
Heparanase is endoglycosidase that degrades heparan sulfate, the main polysaccharide constituent of the extracellular matrix and basement membrane. Heparanase has been thought to have an important role in the process of cancer invasion and metastasis. Recent studies have revealed that heparanase has multifunctional modulatory effects in the progression of cancer cells and the cell-to-extracellular matrix interaction. Our recent research has shown the important roles of heparanase in the progression of esophagus, stomach and colon cancer, and heparanase expression was closely related to the prognosis of gastrointestinal cancer. Therapies targeting heparanase may result in promising tactics in cancer therapies. Heparanase gene silencing and inhibiton of enzymatic activities have potential use as targets for anticancer drug development. Here, we reviewed the role of heparanase in gastrointestinal tract tumors.
乙酰肝素酶是一种内切糖苷酶,可降解硫酸乙酰肝素,硫酸乙酰肝素是细胞外基质和基底膜的主要多糖成分。乙酰肝素酶被认为在癌症侵袭和转移过程中起重要作用。最近的研究表明,乙酰肝素酶在癌细胞进展和细胞与细胞外基质相互作用中具有多功能调节作用。我们最近的研究表明,乙酰肝素酶在食管癌、胃癌和结肠癌的进展中起重要作用,且乙酰肝素酶表达与胃肠道癌的预后密切相关。针对乙酰肝素酶的疗法可能成为癌症治疗中有前景的策略。乙酰肝素酶基因沉默和酶活性抑制有潜力用作抗癌药物开发的靶点。在此,我们综述了乙酰肝素酶在胃肠道肿瘤中的作用。